COLOMBO, BENEDETTA
 Distribuzione geografica
Continente #
EU - Europa 41
NA - Nord America 6
AS - Asia 3
Totale 50
Nazione #
IT - Italia 26
FI - Finlandia 7
CA - Canada 3
GB - Regno Unito 3
US - Stati Uniti d'America 3
NL - Olanda 2
SE - Svezia 2
DE - Germania 1
IQ - Iraq 1
JP - Giappone 1
TR - Turchia 1
Totale 50
Città #
Helsinki 7
Istrana 5
Florence 4
Ashburn 3
Ciampino 3
Naples 3
Rome 3
Segrate 3
Cardiff 2
Huizen 2
Occimiano 2
Borås 1
Dalsjoefors 1
Fiesole 1
London 1
Milan 1
Tokyo 1
Toronto 1
Zanica 1
Totale 45
Nome #
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 12
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 10
Advances on Human Immunodeficiency Virus Type 2 Infection 8
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 6
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 6
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 4
Phylogenetic Analysis of Multi-Drug Resistant Klebsiella pneumoniae Strains From Duodenoscope Biofilm: Microbiological Surveillance and Reprocessing Improvements for Infection Prevention 3
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 1
Totale 50
Categoria #
all - tutte 813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 0 0 0 0 0 20
2022/202313 0 0 0 1 4 0 2 1 3 0 2 0
2023/202417 0 3 1 10 2 1 0 0 0 0 0 0
Totale 50